Acutus Medical, Inc. Just Filed Its Quarterly Report: Net Loss Per Common ...

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted net loss per common share excludes the potential impact of the Company’s convertible preferred stock, common stock options and warrants because their effect would be anti-dilutive due to the Company’s net loss. Since the Company had a net loss in the periods presented, basic and diluted net loss per common share are the same.
The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per common share because to do so would be anti-dilutive:
Nine Months Ended September 30,
Shares issuable upon:20212020
Conversion of Series A Common Equivalent Preferred Stock6,665,841 — 
Exercise of stock options3,961,959 3,416,345 
Exercise of common stock warrants797,487 956,552 
Vesting of PSUs and RSUs861,638 496,592 
Total12,286,925 4,869,489 

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Acutus Medical, Inc. makes a similar move, sign up!

Auto Refresh